FERTILITY NEWS

Adenomyosis

ReproNovo Raises $65 Million Series A Financing to Advance Phase 2 Clinical Trials of Novel Therapies img_aBykFp

ReproNovo Raises $65 Million Series A Financing to Advance Phase 2 Clinical Trials of Novel Therapies

admin May 22, 2025
ReproNovo, a company dedicated to developing innovative treatments for reproductive medicine and women’s health, has successfully closed...
Read More Read more about ReproNovo Raises $65 Million Series A Financing to Advance Phase 2 Clinical Trials of Novel Therapies
Jeito Capital Leads a USD 65 million Financing in ReproNovo to Develop Transformational Treatments in Reproductive Medicine and Women’s Health img_qjnl6q

Jeito Capital Leads a USD 65 million Financing in ReproNovo to Develop Transformational Treatments in Reproductive Medicine and Women’s Health

admin May 21, 2025
Jeito Capital, an independent Private Equity fund specialising in biopharma, is leading a USD 65 million (approx....
Read More Read more about Jeito Capital Leads a USD 65 million Financing in ReproNovo to Develop Transformational Treatments in Reproductive Medicine and Women’s Health

Copyright © 2025 Fertility Insider. Fertility Insider is not responsible for the content of external sites. Read our Privacy Policy.

favpng_9949a7ba494dd49e1f5630de82f218b5
The_Times_logo_wrodmark
Daily_Mail_masthead.svg
5
768px-The_Telegraph.svg
favpng_9949a7ba494dd49e1f5630de82f218b5
5
Daily_Mail_masthead.svg
The_Times_logo_wrodmark
768px-The_Telegraph.svg

Copyright © 2025 Fertility Insider. Fertility Insider is not responsible for the content of external sites. Read our Privacy Policy.

Newsletter

Sign up to our newsletter